首页> 外文期刊>Clinical diabetes and endocrinology. >Thyroid dysfunction in metabolic syndrome patients and its relationship with components of metabolic syndrome
【24h】

Thyroid dysfunction in metabolic syndrome patients and its relationship with components of metabolic syndrome

机译:代谢综合征患者的甲状腺功能障碍及其与代谢综合征组分的关系

获取原文
获取外文期刊封面目录资料

摘要

A growing body of evidence suggests that metabolic syndrome is associated with endocrine disorders including thyroid dysfunction. Thyroid dysfunction in metabolic syndrome patients may further add to cardiovascular disease risk thereby increasing mortality. This study was done to assess thyroid function in metabolic syndrome patients and evaluate its relationship with the components of metabolic syndrome. A cross sectional study was carried out among 169 metabolic syndrome patients at B P Koirala Institute of Health Sciences, Dharan, Nepal. Anthropometric measurements (height, weight, waist circumference) and blood pressure were taken. Fasting blood samples were analysed to measure glucose, triglyceride, high density lipoprotein (HDL) cholesterol and thyroid hormones (triiodothyronine, thyroxine and thyroid stimulating hormone). Thyroid dysfunction was seen in 31.9?% (n?=?54) metabolic syndrome patients. Subclinical hypothyroidism (26.6?%) was the major thyroid dysfunction followed by overt hypothyroidism (3.5?%) and subclinical hyperthyroidism (1.7?%). Thyroid dysfunction was much common in females (39.7?%, n?=?29) than males (26?%, n?=?25) but not statistically significant (p?=?0.068). The relative risk of having thyroid dysfunction in females was 1.525 (CI: 0.983-2.368) as compared to males. Significant differences (p?=?0.001) were observed in waist circumference between patients with and without thyroid dysfunction and HDL cholesterol which had significant negative correlation with thyroid stimulating hormone. Thyroid dysfunction, particularly subclinical hypothyroidism is common among metabolic syndrome patients, and is associated with some components of metabolic syndrome (waist circumference and HDL cholesterol).
机译:越来越多的证据表明代谢综合征与内分泌疾病有关,包括甲状腺功能障碍。代谢综合征患者的甲状腺功能障碍可能进一步增加心血管疾病风险,从而提高了死亡率。完成该研究以评估代谢综合征患者的甲状腺功能,并评估其与代谢综合征组分的关系。在尼泊尔的B P Koirala卫生科学研究所的169名代谢综合征患者中进行了横截面研究。取出人体测量(高度,重量,腰围)和血压。分析空腹血液样品以测量葡萄糖,甘油三酯,高密度脂蛋白(HDL)胆固醇和甲状腺激素(三碘甲醇,甲状腺素和甲状腺刺激激素)。在31.9?%(n?= 54)代谢综合征患者中观察到甲状腺功能障碍。亚临床甲状腺功能减退症(26.6?%)是主要的甲状腺功能障碍,然后是明显的甲状腺功能亢进(3.5?%)和亚临床甲状腺功能亢进(1.7〜7%)。甲状腺功能障碍在女性中常见(39.7?%,n?= 29),而不是男性(26μm,n?= 25)但没有统计学意义(p?= 0.068)。与雄性相比,患有甲状腺功能障碍的相对风险为1.525(CI:0.983-2.368)。在患有甲状功能障碍和HDL胆固醇的患者之间观察到腰围观察到显着差异(p?= 0.001),其与甲状腺刺激激素具有显着的负相关性。甲状腺功能障碍,特别是亚临床甲状腺功能亢进是代谢综合征患者的常见,并且与代谢综合征(腰围和HDL胆固醇)的一些组分相关。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号